Assessment of Doxorubicin Internalization and Cytotoxicity in Primary Tumor Spheroids After Collagen Digestion

Alessandra Lo Cicero1, Gabriele Lo Buglio1,2, Simona Campora1

  • 1Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy.

Current Protocols
|June 1, 2026
PubMed

Insights

This study introduces a new 3D breast tumor model to investigate how the extracellular matrix (ECM) affects chemotherapy delivery and resistance. The model uses primary tumor cells to better understand drug penetration and efficacy in solid tumors.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Cancer Biology

Background:

  • Limited penetration of chemotherapeutic agents into solid tumors is a significant challenge in cancer treatment.
  • The extracellular matrix (ECM) plays a crucial role in regulating drug distribution and efficacy within tumors.
  • Three-dimensional (3D) tumor spheroids from primary tumor cells (PTCs) offer a physiologically relevant in vitro model to study these interactions.

Purpose of the Study:

  • To develop and present integrated protocols for evaluating the impact of ECM remodeling on chemotherapeutic response in primary breast tumor spheroids.
  • To establish a reproducible platform for investigating ECM-mediated barriers to drug delivery and toxicity in 3D tumor models.
  • To facilitate mechanistic studies of microenvironment-driven drug resistance.

Main Methods:

  • Generation of 3D spheroids from isolated primary breast tumor cells.
  • Controlled enzymatic degradation of collagen-rich ECM using recombinant collagenases.
  • Assessment of doxorubicin uptake and spatial distribution via confocal microscopy.
  • Quantification of drug-induced cytotoxicity using a luminescent 3D viability assay.

Main Results:

  • The developed protocols allow for the visualization and quantification of drug penetration and efficacy within a 3D tumor microenvironment.
  • The model effectively recapitulates key features of solid tumors, including collagen deposition and diffusion-limited drug accessibility.
  • The study provides a framework for investigating how ECM composition influences chemotherapeutic response.

Conclusions:

  • The described integrated protocols offer a valuable and accessible platform for studying ECM-mediated drug delivery barriers and toxicity in 3D tumor models.
  • This approach enhances the physiological relevance of in vitro cancer research, aiding the study of drug efficacy and resistance.
  • The findings support the development of more effective cancer therapies by elucidating the role of the tumor microenvironment.

Related Concept Videos